Stock listing

SGP Stock Price, News, Filings & Events — Spyglass Pharma, Inc.

Selected listing: SGP · NASDAQ · USD · US

This page tracks Spyglass Pharma, Inc.'s SGP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SGP:NASDAQ. SGP:NASDAQ is the stock-level entry point for investors researching Spyglass Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Spyglass Pharma, Inc. is a public company traded under the ticker SGP in the American market. With a market capitalization of approximately $685 million, Spyglass Pharma focuses on developing innovative pharmaceutical solutions. The company is committed to advancing healthcare through its research and development efforts.

SGP:NASDAQUSDUSUpdated September 12, 2026
Spyglass Pharma, Inc. logo
Ticker
SGP:NASDAQ
Asset type
Stock
Market cap
$920.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Spyglass Pharma, Inc. SGP:NASDAQ stock context

This page tracks Spyglass Pharma, Inc.'s SGP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SGP:NASDAQ. SGP:NASDAQ is the stock-level entry point for investors researching Spyglass Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Spyglass Pharma, Inc. is a public company traded under the ticker SGP in the American market. With a market capitalization of approximately $685 million, Spyglass Pharma focuses on developing innovative pharmaceutical solutions. The company is committed to advancing healthcare through its research and development efforts.

Latest news from Spyglass Pharma, Inc.

All Spyglass Pharma, Inc. news →

Research Spyglass Pharma, Inc.

Alternate listings